KYMR- Kymera Therapeutics, Inc.

Name: Kymera Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kymera Therapeutics, Inc. (KYMR) has 15 insiders with recent SEC Form 4 filings, including 24 buys and 23 sells. KYMR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Baker Bros. Advisors LP	7.96M	$719.45M	-
Dir	Bvf Partners L P/il	2.22M	$200.74M	-
Dir	Booth Bruce	685.4K	$61.98M	-
CEO	Mainolfi Nello	666.2K	$60.24M	-
CFO	Jacobs Bruce N.	306.6K	$27.73M	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 3, 2022	Atlas Venture Fund X, L.P.69	10% Owner	Sell	220,016	$30.01	$6,602,952.38	-1.7%	+18.3%	-53.8%
Nov 1, 2022	Atlas Venture Fund X, L.P.69	10% Owner	Sell	288,702	$30.26	$8,735,143.37	-1.1%	+21.4%	-61.4%
Nov 1, 2022	Booth Bruce70	Director	Sell	288,702	$30.26	$8,735,143.37	-1.1%	+21.4%	-61.4%
Aug 22, 2022	Bvf Partners L P/il59	Director, See Remarks And Footnotes	Buy	545,525	$26.00	$14,183,650.00	+13.5%	-9.5%	-36.2%
May 27, 2022	Bvf Partners L P/il59	Director, See Remarks And Footnotes	Buy	289,426	$14.34	$4,150,321.26	+3.7%	+114.8%	+95.5%
May 20, 2022	Bvf Partners L P/il59	Director, See Remarks And Footnotes	Buy	10,100	$14.00	$141,393.94	+0.3%	+96.7%	+100.5%
May 6, 2022	Bvf Partners L P/il59	Director, See Remarks And Footnotes	Buy	250,000	$19.46	$4,865,365.00	+3.5%	+47.7%	+52.4%
Jan 31, 2022	Bvf Partners L P/il59	Director, See Remarks	Buy	130,309	$38.96	$5,076,473.14	+2.0%	-22.1%	-11.0%
Jan 24, 2022	Bvf Partners L P/il59	Director, See Remarks	Buy	272,767	$37.76	$10,300,636.60	+9.4%	-13.5%	-6.5%
Jan 12, 2022	Jacobs Bruce N.74	Chief Financial Officer	Sale+OE	15,000	$51.85	$777,684.04	-19.3%	-28.1%	-33.8%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC